| A multigenic program mediating breast cancer metastasis to bone Y Kang, PM Siegel, W Shu, M Drobnjak, SM Kakonen, C Cordón-Cardo, ... Cancer cell 3 (6), 537-549, 2003 | 3317 | 2003 |
| Bisphosphonate‐associated osteonecrosis of the jaw: report of a task force of the American Society for Bone and Mineral Research S Khosla, D Burr, J Cauley, DW Dempster, PR Ebeling, D Felsenberg, ... Journal of bone and mineral research 22 (10), 1479-1491, 2007 | 2032 | 2007 |
| Diagnosis and management of osteonecrosis of the jaw: a systematic review and international consensus AA Khan, A Morrison, DA Hanley, D Felsenberg, LK McCauley, F O'Ryan, ... Journal of Bone and Mineral Research 30 (1), 3-23, 2015 | 1769 | 2015 |
| Cancer to bone: a fatal attraction KN Weilbaecher, TA Guise, LK McCauley Nature Reviews Cancer 11 (6), 411-425, 2011 | 1519 | 2011 |
| TGF-β signaling blockade inhibits PTHrP secretion by breast cancer cells and bone metastases development JJ Yin, K Selander, JM Chirgwin, M Dallas, BG Grubbs, R Wieser, ... The Journal of clinical investigation 103 (2), 197-206, 1999 | 1232 | 1999 |
| Evidence for a causal role of parathyroid hormone-related protein in the pathogenesis of human breast cancer-mediated osteolysis. TA Guise, JJ Yin, SD Taylor, Y Kumagai, M Dallas, BF Boyce, T Yoneda, ... The Journal of clinical investigation 98 (7), 1544-1549, 1996 | 997 | 1996 |
| Primer on the metabolic bone diseases and disorders of mineral metabolism CJ Rosen John Wiley & Sons, 2009 | 892 | 2009 |
| Modulation of mammalian life span by the short isoform of p53 B Maier, W Gluba, B Bernier, T Turner, K Mohammad, T Guise, ... Genes & development 18 (3), 306-319, 2004 | 733 | 2004 |
| Cancer and bone TA Guise, GR Mundy Endocrine reviews 19 (1), 18-54, 1998 | 715 | 1998 |
| Basic mechanisms responsible for osteolytic and osteoblastic bone metastases TA Guise, KS Mohammad, G Clines, EG Stebbins, DH Wong, LS Higgins, ... Clinical cancer research 12 (20), 6213s-6216s, 2006 | 687 | 2006 |
| Breast cancer cells interact with osteoblasts to support osteoclast formation RJ Thomas, TA Guise, JJ Yin, J Elliott, NJ Horwood, TJ Martin, ... Endocrinology 140 (10), 4451-4458, 1999 | 687 | 1999 |
| Guide to bone health and disease in cystic fibrosis RM Aris, PA Merkel, LK Bachrach, DS Borowitz, MP Boyle, SL Elkin, ... The Journal of Clinical Endocrinology & Metabolism 90 (3), 1888-1896, 2005 | 619 | 2005 |
| Molecular biology of bone metastasis LA Kingsley, PGJ Fournier, JM Chirgwin, TA Guise Molecular cancer therapeutics 6 (10), 2609-2617, 2007 | 579 | 2007 |
| Breast cancer metastasis to bone: mechanisms of osteolysis and implications for therapy W Kozlow, TA Guise Journal of mammary gland biology and neoplasia 10 (2), 169-180, 2005 | 500 | 2005 |
| A causal role for endothelin-1 in the pathogenesis of osteoblastic bone metastases JJ Yin, KS Mohammad, SM Käkönen, S Harris, JR Wu-Wong, JL Wessale, ... Proceedings of the National Academy of Sciences 100 (19), 10954-10959, 2003 | 499 | 2003 |
| Excess TGF-β mediates muscle weakness associated with bone metastases in mice DL Waning, KS Mohammad, S Reiken, W Xie, DC Andersson, S John, ... Nature medicine 21 (11), 1262-1271, 2015 | 431 | 2015 |
| Molecular mechanisms of osteolytic bone metastases TA Guise Cancer: Interdisciplinary International Journal of the American Cancer …, 2000 | 404 | 2000 |
| Hypercalcaemia of malignancy and basic research on mechanisms responsible for osteolytic and osteoblastic metastasis to bone GA Clines, TA Guise Endocrine-related cancer 12 (3), 549-583, 2005 | 382 | 2005 |
| Runx2 association with progression of prostate cancer in patients: mechanisms mediating bone osteolysis and osteoblastic metastatic lesions J Akech, JJ Wixted, K Bedard, M Van der Deen, S Hussain, TA Guise, ... Oncogene 29 (6), 811-821, 2010 | 342 | 2010 |
| Osteoporosis in men with prostate carcinoma receiving androgen‐deprivation therapy: recommendations for diagnosis and therapies TH Diamond, CS Higano, MR Smith, TA Guise, FR Singer Cancer 100 (5), 892-899, 2004 | 340 | 2004 |
